Symbol="BMRN"
AssetType="Common Stock"
Name="Biomarin Pharmaceutical Inc"
Description="BioMarin Pharmaceutical Inc. develops and markets therapies for people with rare diseases and serious and life-threatening medical conditions. The company is headquartered in San Rafael, California."
CIK="1048477"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="105 DIGITAL DRIVE, NOVATO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="16465132000"
EBITDA="177139000"
PERatio="237.08"
PEGRatio="0.643"
BookValue="24.84"
DividendPerShare="0"
DividendYield="0"
EPS="0.37"
RevenuePerShareTTM="11.69"
ProfitMargin="0.033"
OperatingMarginTTM="0.035"
ReturnOnAssetsTTM="0.0076"
ReturnOnEquityTTM="0.0158"
RevenueTTM="2173095000"
GrossProfitTTM="1612370000"
DilutedEPSTTM="0.37"
QuarterlyEarningsGrowthYOY="-0.58"
QuarterlyRevenueGrowthYOY="0.148"
AnalystTargetPrice="119.22"
TrailingPE="237.08"
ForwardPE="31.25"
PriceToSalesRatioTTM="10.05"
PriceToBookRatio="4.409"
EVToRevenue="9.94"
EVToEBITDA="90.91"
Beta="0.366"
num_52WeekHigh="117.77"
num_52WeekLow="80.53"
num_50DayMovingAverage="90.57"
num_200DayMovingAverage="96.48"
SharesOutstanding="187701000"
DividendDate="None"
ExDividendDate="None"
symbol="BMRN"
open="87.91"
high="88.30"
low="87.38"
price="87.72"
volume="1212370.00"
latest_trading_day="2023-07-21"
previous_close="87.54"
change="0.18"
change_percent="0.2056%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="1307648"
Change_recent_avg="-0.08"
Delta_recent_avg="2.17"
Variance_recent_avg="1.09"
Change_ratio_recent_avg="-0.1"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="499"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0106.jpeg"
image_negative_thumbnail_id_2="1098"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0131.jpeg"
image_neutral_thumbnail_id_1="529"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0070.jpeg"
image_neutral_thumbnail_id_2="539"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0060.jpeg"
image_positive_thumbnail_id_1="645"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0063.jpeg"
image_positive_thumbnail_id_2="615"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0093.jpeg"
image_professor_thumbnail_id_1="1195"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
image_professor_thumbnail_id_2="1177"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0011.jpeg"
